PetCaseFinder

Peer-reviewed veterinary case report

Signs and radiation treatment of frontal sinus cancer in dogs

By Loddo, Pietro et al.·Published in Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·2025·Queen's Veterinary School Hospital, United Kingdom·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Clinical Presentation of Frontal Sinus Squamous Cell Carcinoma in the Dog and Response to Treatment With Radiation Therapy in Eight Dogs.

Species:
dog

Plain-English summary

An 8-year-old mixed-breed dog was diagnosed with a rare type of cancer called frontal sinus squamous cell carcinoma, which can cause issues like nasal discharge and swelling around the face. The dog received radiation therapy, which is a common treatment for this type of cancer. While the dog lived for 36 months after treatment, the average survival time for the group of dogs treated was about 7.5 months. This suggests that radiation therapy can be a helpful option for dogs with this specific cancer, especially if other treatment methods are not available.

People also search for: dog nasal discharge cancer · frontal sinus cancer treatment in dogs · radiation therapy for dog tumors

Abstract

Primary frontal sinus squamous cell carcinoma (PFSSCC) represents a rare disease in dogs, and there is a general paucity of information in the current veterinary literature regarding its presentation and response to radiation therapy. The objective of this retrospective observational study was to describe a series of dogs diagnosed with PFSSCC and report their response to radiation therapy. Medical records of dogs with a diagnosis of PFSSCC were reviewed. Data collected included signalment, presenting complaint, clinicopathologic and diagnostic imaging findings, treatment, therapeutic response, and date of death or last follow-up. Eight cases of PFSSCC in dogs were treated with radiation therapy at the authors' institution. Three of these dogs were treated with coarse-fractionated radiation therapy. One dog was euthanized due to an unrelated cause 36 months after completing the radiation therapy. The second and third dogs survived 18 and 3 months, respectively, from the end of treatment to death due to PFSCC. Five further dogs were treated with a more fractionated protocol (Monday-Wednesday-Friday schedule). The median survival time for all patients was 7.5 months (range 2-36 months). Despite the small number of cases and variation in the radiation protocols used, the treatment outcomes in these eight dogs suggest that radiation therapy is potentially a viable treatment option for dogs with PFSSCC and that coarse fractionation might be an appropriate approach if more finely fractionated protocols are not possible.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/39757699/